Brief: Abivax Sa Says Cash And Cash Equivalents Of Eur 180.5 Million As Of September 30, 2024
Nov 14 (Reuters) - Abivax SA ABVX.PA :
* EQS-NEWS: ABIVAX PRESENTS THIRD QUARTER 2024 KEY FINANCIAL
INFORMATION
* ABIVAX SA - CASH AND CASH EQUIVALENTS OF EUR 180.5 MILLION
AS OF
SEPTEMBER 30, 2024
* ABIVAX SA - EXPECTS TO BE ABLE TO FUND ITS OPERATIONS INTO
Q4
2025
Source text: ID:nEQl3ttVa
Further company coverage: ABVX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data